Almost all exploration companies on the ASX trade cum capital raising. The issue is the manner in a company raises new capital. If you are going to raise at a big discount then it is prudent to offer this as an entitlement to your own shareholders first and have the broker act as an underwriter or manager to place any shortfall.
AZY is uniquely placed when compared to most explorers and has good prospects of becoming a miner with ongoing success. If a placement was determined to be the best option because of the "exceptional demand", then they should have used their enviable position to negotiate better terms with the brokers (including those already involved and the many others that have been active in the stock).
PS: still angry but fortunately the cat was already fed when I got home
- Forums
- ASX - By Stock
- AZY
- Ann: Antipa Raises $5.1M to Accelerate Exploration & Development
Ann: Antipa Raises $5.1M to Accelerate Exploration & Development, page-30
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AZY (ASX) to my watchlist
|
|||||
Last
1.2¢ |
Change
0.001(9.09%) |
Mkt cap ! $56.52M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.2¢ | $42.55K | 3.551M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
26 | 14226218 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 12565248 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
25 | 14201663 | 0.011 |
54 | 20952853 | 0.010 |
32 | 13709155 | 0.009 |
15 | 7739820 | 0.008 |
4 | 2250000 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 11815248 | 12 |
0.013 | 10067216 | 7 |
0.014 | 6141789 | 9 |
0.015 | 3568929 | 8 |
0.016 | 4915631 | 11 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
AZY (ASX) Chart |